Luspatercept in β‐thalassemia: Who and when. Strengths and weaknesses points of a real‐world evidence

Saved in:
Bibliographic Details
Main Authors: Lorenza Torti, Nicolina Ardu, Laura Maffei, Paolo De Fabritiis, Francesco Sorrentino
Format: Article
Language:English
Published: Wiley 2024-12-01
Series:eJHaem
Subjects:
Online Access:https://doi.org/10.1002/jha2.1032
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850064503730864128
author Lorenza Torti
Nicolina Ardu
Laura Maffei
Paolo De Fabritiis
Francesco Sorrentino
author_facet Lorenza Torti
Nicolina Ardu
Laura Maffei
Paolo De Fabritiis
Francesco Sorrentino
author_sort Lorenza Torti
collection DOAJ
format Article
id doaj-art-40ec85c6a9eb4dffa7e3395fe0bd79cd
institution DOAJ
issn 2688-6146
language English
publishDate 2024-12-01
publisher Wiley
record_format Article
series eJHaem
spelling doaj-art-40ec85c6a9eb4dffa7e3395fe0bd79cd2025-08-20T02:49:17ZengWileyeJHaem2688-61462024-12-01561354135810.1002/jha2.1032Luspatercept in β‐thalassemia: Who and when. Strengths and weaknesses points of a real‐world evidenceLorenza Torti0Nicolina Ardu1Laura Maffei2Paolo De Fabritiis3Francesco Sorrentino4Hemoglobinopathies Unit, Hematology Department, S. Eugenio Hospital (ASL Roma 2) Regional Center for the Diagnosis and Treatment of Rare Anemias and Disorders of Iron Metabolism Rome ItalyHemoglobinopathies Unit, Hematology Department, S. Eugenio Hospital (ASL Roma 2) Regional Center for the Diagnosis and Treatment of Rare Anemias and Disorders of Iron Metabolism Rome ItalyHemoglobinopathies Unit, Hematology Department, S. Eugenio Hospital (ASL Roma 2) Regional Center for the Diagnosis and Treatment of Rare Anemias and Disorders of Iron Metabolism Rome ItalyHemoglobinopathies Unit, Hematology Department, S. Eugenio Hospital (ASL Roma 2) Regional Center for the Diagnosis and Treatment of Rare Anemias and Disorders of Iron Metabolism Rome ItalyHemoglobinopathies Unit, Hematology Department, S. Eugenio Hospital (ASL Roma 2) Regional Center for the Diagnosis and Treatment of Rare Anemias and Disorders of Iron Metabolism Rome Italyhttps://doi.org/10.1002/jha2.1032adverse eventsluspaterceptthalassemiathrombocytosistransfusional therapy
spellingShingle Lorenza Torti
Nicolina Ardu
Laura Maffei
Paolo De Fabritiis
Francesco Sorrentino
Luspatercept in β‐thalassemia: Who and when. Strengths and weaknesses points of a real‐world evidence
eJHaem
adverse events
luspatercept
thalassemia
thrombocytosis
transfusional therapy
title Luspatercept in β‐thalassemia: Who and when. Strengths and weaknesses points of a real‐world evidence
title_full Luspatercept in β‐thalassemia: Who and when. Strengths and weaknesses points of a real‐world evidence
title_fullStr Luspatercept in β‐thalassemia: Who and when. Strengths and weaknesses points of a real‐world evidence
title_full_unstemmed Luspatercept in β‐thalassemia: Who and when. Strengths and weaknesses points of a real‐world evidence
title_short Luspatercept in β‐thalassemia: Who and when. Strengths and weaknesses points of a real‐world evidence
title_sort luspatercept in β thalassemia who and when strengths and weaknesses points of a real world evidence
topic adverse events
luspatercept
thalassemia
thrombocytosis
transfusional therapy
url https://doi.org/10.1002/jha2.1032
work_keys_str_mv AT lorenzatorti luspaterceptinbthalassemiawhoandwhenstrengthsandweaknessespointsofarealworldevidence
AT nicolinaardu luspaterceptinbthalassemiawhoandwhenstrengthsandweaknessespointsofarealworldevidence
AT lauramaffei luspaterceptinbthalassemiawhoandwhenstrengthsandweaknessespointsofarealworldevidence
AT paolodefabritiis luspaterceptinbthalassemiawhoandwhenstrengthsandweaknessespointsofarealworldevidence
AT francescosorrentino luspaterceptinbthalassemiawhoandwhenstrengthsandweaknessespointsofarealworldevidence